Fidelity Investments’s Palisade Bio PALI Stock Holding History

Fidelity Investments’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15K	Buy	+551	New	+$1.08K	﹤0.01%	5219
2026 Q1	–	Sell	-10	Closed	-$24	–	5528
2025 Q4	$24	Buy	+10	New	+$19	﹤0.01%	5346
2024 Q2	–	Hold	0	–	-$1	–	5569
2024 Q1	–	Sell	-3	Closed	-$21	–	5334
2023 Q4	$22	Buy	+3	New	+$26	﹤0.01%	5190
2022 Q4	–	Sell	-27	Closed	-$2K	–	5522
2022 Q3	$2K	Buy	+27	New	+$5.72K	﹤0.01%	4574
2021 Q1	–	Hold	0	–	–	–	4388
2020 Q4	–	Hold	0	–	–	–	4172
2018 Q4	–	Hold	0	–	–	–	3966
2018 Q3	–	Hold	0	–	–	–	3721

Other funds holding PALI

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Fidelity Investments's PALI Position: Q2 2026 in Review

Fidelity Investments opened a new position in Palisade Bio (PALI) in Q2 2026: 551 shares worth $1.15K. The stake represents ﹤0.01% of the portfolio and ranks #5219 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in PALI as recently as Q4 2025.

Fidelity Investments first reported a position in PALI in Q3 2022 and has held it in 4 quarters since. The position peaked at $2K in Q3 2022. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

Fidelity Investments held 551 shares of Palisade Bio worth $1.15K as of Q2 2026.
Palisade Bio was a new Fidelity Investments position in Q2 2026.
Palisade Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5219 holding.
Fidelity Investments first reported a position in Palisade Bio in Q3 2022 and has held it in 4 quarters since.
Fidelity Investments's Palisade Bio position peaked at $2K in Q3 2022.
124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.